vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and OP Bancorp (OPBK). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $24.3M, roughly 2.0× OP Bancorp). On growth, OP Bancorp posted the faster year-over-year revenue change (13.7% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $23.4M). Over the past eight quarters, OP Bancorp's revenue compounded faster (11.4% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
OP Bancorp is the bank holding company for Open Bank, a community-oriented commercial bank headquartered in California, United States. It provides a full range of banking solutions including deposit accounts, commercial real estate loans, small business financing, and consumer lending products, primarily catering to small and medium-sized enterprises, local immigrant communities, and retail clients across Southern California.
IRWD vs OPBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $24.3M |
| Net Profit | $-2.3M | — |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 39.2% |
| Net Margin | -4.8% | — |
| Revenue YoY | -47.3% | 13.7% |
| Net Profit YoY | -200.9% | — |
| EPS (diluted) | $0.01 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $24.3M | ||
| Q3 25 | $122.1M | $24.5M | ||
| Q2 25 | $85.2M | $23.7M | ||
| Q1 25 | $41.1M | $22.2M | ||
| Q4 24 | $90.5M | $21.3M | ||
| Q3 24 | $91.6M | $20.7M | ||
| Q2 24 | $94.4M | $20.4M | ||
| Q1 24 | $74.9M | $19.6M |
| Q4 25 | $-2.3M | — | ||
| Q3 25 | $40.1M | $6.7M | ||
| Q2 25 | $23.6M | $6.3M | ||
| Q1 25 | $-37.4M | $5.6M | ||
| Q4 24 | $2.3M | — | ||
| Q3 24 | $3.6M | $5.4M | ||
| Q2 24 | $-860.0K | $5.4M | ||
| Q1 24 | $-4.2M | $5.2M |
| Q4 25 | 14.3% | 39.2% | ||
| Q3 25 | 61.8% | 39.5% | ||
| Q2 25 | 53.2% | 35.7% | ||
| Q1 25 | -70.7% | 34.6% | ||
| Q4 24 | 34.8% | 31.2% | ||
| Q3 24 | 28.0% | 36.5% | ||
| Q2 24 | 26.5% | 37.2% | ||
| Q1 24 | 14.7% | 37.1% |
| Q4 25 | -4.8% | — | ||
| Q3 25 | 32.8% | 27.4% | ||
| Q2 25 | 27.7% | 26.7% | ||
| Q1 25 | -90.9% | 25.0% | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 4.0% | 26.2% | ||
| Q2 24 | -0.9% | 26.7% | ||
| Q1 24 | -5.6% | 26.7% |
| Q4 25 | $0.01 | $0.48 | ||
| Q3 25 | $0.23 | $0.45 | ||
| Q2 25 | $0.14 | $0.42 | ||
| Q1 25 | $-0.23 | $0.37 | ||
| Q4 24 | $0.03 | $0.33 | ||
| Q3 24 | $0.02 | $0.36 | ||
| Q2 24 | $-0.01 | $0.36 | ||
| Q1 24 | $-0.03 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $167.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $227.9M |
| Total Assets | $396.9M | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $167.3M | ||
| Q3 25 | $140.4M | $166.7M | ||
| Q2 25 | $92.9M | $205.4M | ||
| Q1 25 | $108.5M | $198.9M | ||
| Q4 24 | $88.6M | $134.9M | ||
| Q3 24 | $88.2M | $166.8M | ||
| Q2 24 | $105.5M | $127.7M | ||
| Q1 24 | $121.5M | $139.2M |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $227.9M | ||
| Q3 25 | $-264.2M | $221.5M | ||
| Q2 25 | $-308.2M | $213.7M | ||
| Q1 25 | $-334.1M | $210.1M | ||
| Q4 24 | $-301.3M | $205.0M | ||
| Q3 24 | $-311.3M | $203.6M | ||
| Q2 24 | $-321.7M | $195.9M | ||
| Q1 24 | $-330.5M | $194.7M |
| Q4 25 | $396.9M | $2.7B | ||
| Q3 25 | $396.1M | $2.6B | ||
| Q2 25 | $342.9M | $2.6B | ||
| Q1 25 | $327.2M | $2.5B | ||
| Q4 24 | $350.9M | $2.4B | ||
| Q3 24 | $389.5M | $2.4B | ||
| Q2 24 | $395.6M | $2.3B | ||
| Q1 24 | $438.8M | $2.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $26.2M |
| Free Cash FlowOCF − Capex | $74.6M | $23.4M |
| FCF MarginFCF / Revenue | 156.3% | 96.2% |
| Capex IntensityCapex / Revenue | 0.0% | 11.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $43.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $26.2M | ||
| Q3 25 | $47.6M | $23.9M | ||
| Q2 25 | $-15.1M | $-7.0M | ||
| Q1 25 | $20.0M | $5.6M | ||
| Q4 24 | $15.2M | $31.2M | ||
| Q3 24 | $9.9M | $13.3M | ||
| Q2 24 | $33.5M | $15.8M | ||
| Q1 24 | $45.0M | $-3.2M |
| Q4 25 | $74.6M | $23.4M | ||
| Q3 25 | $47.6M | $23.4M | ||
| Q2 25 | $-15.1M | $-7.7M | ||
| Q1 25 | $19.9M | $4.2M | ||
| Q4 24 | — | $29.7M | ||
| Q3 24 | $9.9M | $12.8M | ||
| Q2 24 | $33.4M | $15.7M | ||
| Q1 24 | $44.9M | $-3.2M |
| Q4 25 | 156.3% | 96.2% | ||
| Q3 25 | 39.0% | 95.6% | ||
| Q2 25 | -17.7% | -32.5% | ||
| Q1 25 | 48.4% | 19.0% | ||
| Q4 24 | — | 139.0% | ||
| Q3 24 | 10.8% | 61.5% | ||
| Q2 24 | 35.4% | 77.0% | ||
| Q1 24 | 60.0% | -16.6% |
| Q4 25 | 0.0% | 11.5% | ||
| Q3 25 | 0.0% | 2.3% | ||
| Q2 25 | 0.0% | 3.0% | ||
| Q1 25 | 0.1% | 6.4% | ||
| Q4 24 | 0.0% | 7.3% | ||
| Q3 24 | 0.0% | 2.8% | ||
| Q2 24 | 0.1% | 0.4% | ||
| Q1 24 | 0.1% | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | 3.57× | ||
| Q2 25 | -0.64× | -1.10× | ||
| Q1 25 | — | 1.02× | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | 2.45× | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | — | -0.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
